Byrna Technologies Inc. 8-K

What Happened
Byrna Technologies, Inc. announced on July 7, 2026 that it entered into an Asset Purchase Agreement to acquire substantially all assets related to HERO Defense Systems, LLC’s less‑lethal defense products business. The total purchase price is $1,250,000 ( $625,000 cash + $625,000 in restricted common stock), plus a royalty arrangement; the company expects the closing within about 30 days but the agreement can be terminated if not closed by September 30, 2026. A press release announcing the deal was furnished on July 8, 2026.

Key Details

• Purchase price: $1,250,000 total — $625,000 cash (of which $125,000 deposited into escrow at closing) and $625,000 in restricted Byrna common stock; stock shares calculated using 60‑day VWAP and capped at 104,000 shares (subject to anti‑dilution adjustment).
• Royalty: 3.5% of net sales on specified HERO products and derivatives, with a guaranteed minimum of $250,000 (payable as five annual $50,000 installments); royalty ends upon $5,000,000 aggregate payments or five years after closing, whichever is earlier.
• Escrow & indemnities: $125,000 cash holdback in escrow for up to 18 months to secure indemnification claims (released 50% at 12 months and remaining 50% at 18 months, net of claims/reserves); founders provide limited guarantees for certain indemnities.
• Other terms: stock issued as restricted securities (private placement, six‑month contractual lock‑up plus Rule 144 transfer limits); Hero and its founders will enter five‑year non‑compete and non‑solicit covenants and provide transition assistance.

Why It Matters
This acquisition brings HERO’s less‑lethal product IP, inventory and related business into Byrna, potentially expanding its product offerings and revenue sources tied to HERO products. The deal uses a modest cash payment and equity, which could cause limited dilution (up to 104,000 shares maximum) and adds a royalty obligation that guarantees at least $250,000 to Hero over five years and could cost up to $5M in aggregate royalties. Investors should note the escrow and indemnity protections, the founders’ non‑compete/transition commitments, and that the transaction is subject to customary closing conditions and may not close within the expected timeframe.